ASHLEY BEALL MD NPI 1164443511

NPI Details

Ashley Beall, MD is a rheumatology internal medicine in Rockville, MD with 27 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Ashley Beall, MD NPI is 1164443511. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:1999

The provider's business location address is:

14995 SHADY GROVE RD STE 250
ROCKVILLE, MD
ZIP 20850-726
Phone: (301) 942-7600
Fax: (301) 217-9241

The NPI 1164443511 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• X-ray of knee, 3 views (HCPCS:73562)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• X-ray of hand, 2 views (HCPCS:73120)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Destruction of peripheral nerve or branch (HCPCS:64640)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Screening test for antibody to noninfectious agent (HCPCS:86255)
• Rheumatoid factor level (HCPCS:86431)
• Uric acid level, blood (HCPCS:84550)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Protein measurement, serum (HCPCS:84165)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes (HCPCS:97112)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• X-ray of both hips, 2 views (HCPCS:73521)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Therapy procedure using functional activities (HCPCS:97530)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Screening test for pathogenic organisms (HCPCS:87081)
• Body fluid cell count with cell identification (HCPCS:89051)
• Crystal identification from tissue or body fluid (HCPCS:89060)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Injection into tendon or ligament (HCPCS:20550)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection into tendon at attachment to bone or muscle (HCPCS:20551)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Screening test for autoimmune disorder (HCPCS:86038)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Total protein level, blood (HCPCS:84155)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Urine calcium level (HCPCS:82340)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 7/21/2006 and was last updated on 11/24/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.